2024
Disorders with Ophthalmic and Thoracic Involvement.
Gosangi B, Lang P, Johnson M, Zukerman R, Tu L, Traube L, Bader A, Rubinowitz A. Disorders with Ophthalmic and Thoracic Involvement. RadioGraphics 2024, 44: e230132. PMID: 38870047, DOI: 10.1148/rg.230132.Peer-Reviewed Original ResearchConceptsClinical manifestationsExamination of family membersEhlers-Danlos syndromeAffecting patient outcomesAcute sarcoidosisOphthalmologic examinationThoracic symptomsDry eyeThoracic involvementOphthalmological symptomsOphthalmologic manifestationsEye symptomsMarfan syndromeSjogren's syndromeImaging findingsRadiological studiesLung diseasePatient outcomesEhlers-DanlosFamily membersMultimodal imagingSystem conditionsSyndromeThoracicSarcoidosis
2023
Hydroxychloroquine in Stage 1 Type 1 Diabetes.
Libman I, Bingley P, Becker D, Buckner J, DiMeglio L, Gitelman S, Greenbaum C, Haller M, Ismail H, Krischer J, Moore W, Moran A, Muir A, Raman V, Steck A, Toledo F, Wentworth J, Wherrett D, White P, You L, Herold K, Steck A, Greenbaum C, Lord S, Monzavi R, Katz L, Goland R, Muir A, Apperson E, DiMeglio L, Cummings E, Weinstock R, Gaglia J, Campbell F, Cabrera S, Nakhle S, English P, Huynh T, Liljenquist D, Moudiotis C, Duke S, Bosi E, Griffin K, Borg H, Lernmark A, Flynn D, Wilson D, Craig M, Moore W, Wherrett D, Tatovich D, Gitelman S, Philipson L, Haller M, Knip M, Tsalikian E, Baidal D, Thomas I, Moran A, Libman I, White P, Raman V, Raleigh Z, Solorzano C, Rodriguez H, Russell W, So M, Colman P, Couper J, Sherr J. Hydroxychloroquine in Stage 1 Type 1 Diabetes. Diabetes Care 2023, 46: 2035-2043. PMID: 37708415, PMCID: PMC10620539, DOI: 10.2337/dc23-1096.Peer-Reviewed Original ResearchConceptsAnnual ophthalmologic examinationsMedian follow-upStage 1 diseaseHydroxychloroquine armPreplanned secondary analysisAutoantibodies to GADData Safety Monitoring BoardAnti-insulin autoantibodiesSafety monitoring boardType 1 diabetesInnate immune responseOphthalmologic examinationPositive autoantibodiesAnti-GADHydroxychloroquine treatmentMonth 6Oral glucoseFollow-upDrug treatmentImmune responseHydroxychloroquineAutoantibodiesTransient decreaseMonitoring boardReduced titers
2011
Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome
Chaudhry I, Morales J, Shamsi F, Al-Rashed W, Elzaridi E, Arat Y, Jacquemin C, Oystreck D, Bosley T. Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome. Eye 2011, 26: 583-592. PMID: 22193879, PMCID: PMC3325560, DOI: 10.1038/eye.2011.336.Peer-Reviewed Original ResearchConceptsSurgical interventionNon-comparative case seriesDecreased visual acuityNeurofibromatosis type 1Ophthalmologic examinationOphthalmological monitoringPtosis repairTumor debulkingEyelid swellingVisual acuityResultsSixty patientsSurgical managementCase seriesPresenting signCosmetic consequencesCosmetic rehabilitationProcedural outcomesPatientsMedical recordsType 1Medical CentreMultiple proceduresClinical observationsDemographic dataPtosisThe Globe: Infection, Inflammation, and Systemic Disease
Platnick J, Crum AV, Soohoo S, Cedeño PA, Johnson MH. The Globe: Infection, Inflammation, and Systemic Disease. Seminars In Ultrasound CT And MRI 2011, 32: 38-50. PMID: 21277490, DOI: 10.1053/j.sult.2010.12.003.Peer-Reviewed Original ResearchConceptsSystemic diseaseOcular painVision lossClinical ophthalmologic examinationProgressive visual lossAssociated systemic diseaseProgressive vision lossAcute presentationVisual lossDisease extentOphthalmologic examinationClinical symptomatologyDifferential diagnosisComputed tomographyRed eyeDiseasePainInflammationSelective useInfectionDiagnosisMagnetic resonancePathologySymptomatologyOcular Neoplastic Disease
Mahajan A, Crum A, Johnson MH, Materin MA. Ocular Neoplastic Disease. Seminars In Ultrasound CT And MRI 2011, 32: 28-37. PMID: 21277489, DOI: 10.1053/j.sult.2010.12.001.Peer-Reviewed Original ResearchConceptsClinical ophthalmologic examinationOphthalmologic examinationScan ultrasoundCommon imaging appearancesMagnetic resonance imagingOcular metastasisOcular oncologistRetinal detachmentVisual disturbancesFluorescein angiographyMalignant neoplasmsMass lesionImaging appearancesTumor stagingVision lossDiagnostic findingsOcular neoplasmsUveal melanomaNeoplastic diseaseResonance imagingTreatment assessmentNeoplasmsStagingUltrasoundExaminationOcular Anatomy and Cross-Sectional Imaging of the Eye
Malhotra A, Minja FJ, Crum A, Burrowes D. Ocular Anatomy and Cross-Sectional Imaging of the Eye. Seminars In Ultrasound CT And MRI 2011, 32: 2-13. PMID: 21277487, DOI: 10.1053/j.sult.2010.10.009.Peer-Reviewed Original ResearchConceptsCross-sectional imagingTomography/magnetic resonance imagingClinical ophthalmologic examinationPotential clinical indicationsModality of choiceAssessment of extensionMagnetic resonance imagingOcular metastasisChoroidal detachmentRetinal massChoroidal hemangiomaOphthalmologic examinationOcular ultrasoundClinical indicationsTraumatic injuryVitreous cavityForeign bodyUveal melanomaOcular imagingResonance imagingOcular anatomySoft tissueShort scanning timeMRICT
2007
Primary Malignant Melanoma of the Transverse Colon: Report of a Case and Review of the Literature
Kenney B, Dotto J, Homer R, Shafi N, Davydova L. Primary Malignant Melanoma of the Transverse Colon: Report of a Case and Review of the Literature. International Journal Of Surgical Pathology 2007, 15: 401-407. PMID: 17913951, DOI: 10.1177/1066896907302370.Peer-Reviewed Original ResearchConceptsPrimary malignant melanomaMalignant melanomaTransverse colonAfrican American male patientGastrointestinal involvementMale patientsOphthalmologic examinationSmall bowelPrimary lesionResection specimenPrimary melanomaImmunohistochemical positivityGastrointestinal tractMelanomaColonMicroscopic examinationMetastatic phenomenonExaminationMost casesBowelAnorectumPatientsEsophagusLesionsTumorsChoroidal and Optic Nerve Infarction in Hepatitis C-Associated Polyarteritis Nodosa
Kostina-O'Neil Y, Jirawuthiworavong GV, Podell DN, Lesser RL. Choroidal and Optic Nerve Infarction in Hepatitis C-Associated Polyarteritis Nodosa. Journal Of Neuro-Ophthalmology 2007, 27: 184-188. PMID: 17895818, DOI: 10.1097/wno.0b013e31814b1d29.Peer-Reviewed Original ResearchConceptsOptic nerve infarctionPolyarteritis nodosaNerve infarctionBilateral optic disc edemaCase of PANPolymerase chain reaction testingBilateral subdural hematomasOptic disc edemaDisc edemaHepatitis CAcute vasculitisHepatitis C.Choroidal lesionsVisual lossOphthalmologic examinationSubdural hematomaTesticular torsionReaction testingWeight lossInfarctionNodosaVasculitisHematomaPansinusitisEarlier findings
1999
Optic Neuropathy Following Amiodarone Therapy
SREIH A, SCHOENFELD M, MARIEB M. Optic Neuropathy Following Amiodarone Therapy. Pacing And Clinical Electrophysiology 1999, 22: 1108-1110. PMID: 10456646, DOI: 10.1111/j.1540-8159.1999.tb00582.x.Peer-Reviewed Original ResearchConceptsOptic neuropathyAmiodarone therapyComplete ophthalmologic examinationDoses of amiodaroneYears of ageBilateral involvementRandomized studyOphthalmologic examinationUnilateral involvementOcular changesTrue incidenceElectrophysiology practiceSuch therapyFirst symptomsPatientsOcular fundusNeuropathyTherapyPoor healthAmiodaroneCareful evaluationTreatmentInvolvementMedicationsComplications
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply